Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/03/20
End: 08/20/21
Due: 08/20/22
Phase: N/A
Priority: Normal
Start: 08/11/23
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 07/27/23
End: 07/02/29
Due: 07/02/30
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate Cancer | NCT04428203 | Zin W Myint | user2@example.com | None | 2020-08-03 | 2021-08-20 | 2022-08-20 | - | - | 2025-07-14 |
| ArtemiCoffee in Patients With Rising PSA | NCT05478239 | Zin W Myint | user2@example.com | None | 2023-08-11 | 2026-12-31 | 2027-12-31 | - | - | 2025-07-14 |
| Pembro With Radiation With or Without Olaparib | NCT05568550 | Zin W Myint | user2@example.com | None | 2023-07-27 | 2029-07-02 | 2030-07-02 | - | - | 2025-07-14 |